130 related articles for article (PubMed ID: 36017845)
1. QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.
Lian Z; Tai Y; Xia H; Zhai H
Anticancer Agents Med Chem; 2023; 23(6):726-733. PubMed ID: 36017845
[TBL] [Abstract][Full Text] [Related]
2. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.
Wang M; Qiu B; Wang W; Li X; Huo H
Anticancer Agents Med Chem; 2023; 23(19):2146-2153. PubMed ID: 37653634
[TBL] [Abstract][Full Text] [Related]
3. Tit Structure-activity Relationship Study and Design of Novel 1, 8- Naphthimide Derivatives as Potential DNA-targeting Chemotherapeutic Agents for Osteosarcoma.
Lian Z; Si H; Xia H; Zhai H
Med Chem; 2023; 19(9):906-914. PubMed ID: 37066772
[TBL] [Abstract][Full Text] [Related]
4. 3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.
Zhuo W; Lian Z; Bai W; Chen Y; Xia H
Front Mol Biosci; 2023; 10():1164349. PubMed ID: 37065446
[No Abstract] [Full Text] [Related]
5. 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma.
Lian Z; Sang C; Li N; Zhai H; Bai W
Front Pharmacol; 2023; 14():1124895. PubMed ID: 36895941
[No Abstract] [Full Text] [Related]
6. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.
Ren R; Gao L; Li G; Wang S; Zhao Y; Wang H; Liu J
Front Pharmacol; 2023; 14():1177282. PubMed ID: 37089961
[No Abstract] [Full Text] [Related]
7. Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma.
Pan M; Cheng L; Wang Y; Lyu C; Hou C; Zhang Q
Front Pharmacol; 2023; 14():1249041. PubMed ID: 37719847
[No Abstract] [Full Text] [Related]
8. Prediction on the inhibition ratio of pyrrolidine derivatives on matrix metalloproteinase based on gene expression programming.
Li Y; You G; Jia B; Si H; Yao X
Biomed Res Int; 2014; 2014():210672. PubMed ID: 24971318
[TBL] [Abstract][Full Text] [Related]
9. Novel quantitative structure-activity relationship model to predict activities of natural products against COVID-19.
Si Y; Xu X; Hu Y; Si H; Zhai H
Chem Biol Drug Des; 2021 Apr; 97(4):978-983. PubMed ID: 33386649
[TBL] [Abstract][Full Text] [Related]
10. QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease.
Song F; Sun H; Ma X; Wang W; Luan M; Zhai H; Su G; Liu Y
Front Pharmacol; 2023; 14():1185004. PubMed ID: 37266150
[No Abstract] [Full Text] [Related]
11. QSAR Study for Carcinogenic Potency of Aromatic Amines Based on GEP and MLPs.
Song F; Zhang A; Liang H; Cui L; Li W; Si H; Duan Y; Zhai H
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27854309
[TBL] [Abstract][Full Text] [Related]
12. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
[TBL] [Abstract][Full Text] [Related]
13. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking.
Wang JL; Li L; Hu MB; Wu B; Fan WX; Peng W; Wei DN; Wu CJ
Comput Biol Chem; 2019 Feb; 78():297-305. PubMed ID: 30605855
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
15. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
16. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
Alam S; Khan F
Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
[TBL] [Abstract][Full Text] [Related]
17. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
18. A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives.
Wu L; Chen Y; Duan K
Front Pharmacol; 2023; 14():1263933. PubMed ID: 37829302
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship and molecular docking studies on designing inhibitors of the perforin.
Song F; Cui L; Piao J; Liang H; Si H; Duan Y; Zhai H
Chem Biol Drug Des; 2017 Oct; 90(4):535-544. PubMed ID: 28296049
[TBL] [Abstract][Full Text] [Related]
20. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
